Chinese Journal of Cancer : Impact Factor & More
eISSN: 1944-446XpISSN: 1000-467X
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Chinese Journal of Cancer
Chinese Journal of Cancer Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | BMC |
| Language | English |
| Article Processing Charges | GBP 1370 |
| Publication Time | 12 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Chinese Anti-Cancer Association; US Chinese Anti-Cancer Association |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Chinese Journal of Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Chinese Journal of Cancer
Enhancing Non-small Cell Lung Cancer Susceptibility to Anti-PD-1/PD-L1 Therapy through PD-L1 Ligand\u2013Ir(III) Complex Conjugates
- 23 Apr 2026
- Cancer Communications
Dysregulated Proline Metabolism Exacerbates Hepatocellular Carcinoma Metastasis via EPRS1-Mediated mRNA Translation.
- 17 Apr 2026
- Cancer communications (London, England)
EPO receptor blockade in dendritic cell enhances antitumor CD8⁺ T cell immunity
- 14 Apr 2026
- Cancer Communications
The Roles of Protein S-Palmitoylation in Cancers: From Dynamic Modulation to Therapeutic Potential
- 2 Apr 2026
- Cancer Communications
Rezivertinib in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Central Nervous System Metastasis: Central Nervous System Efficacy from the Phase III REZOR Study
- 31 Mar 2026
- Cancer Communications
DKK1 Suppresses Hippo Signaling via PIP3-OGT-LRP6 O-GlcNAcylation in Hepatocellular Carcinoma
- 27 Mar 2026
- Cancer Communications
Enhancing Non-small Cell Lung Cancer Susceptibility to Anti-PD-1/PD-L1 Therapy through PD-L1 Ligand\u2013Ir(III) Complex Conjugates
- 23 Apr 2026
- Cancer Communications
Dysregulated Proline Metabolism Exacerbates Hepatocellular Carcinoma Metastasis via EPRS1-Mediated mRNA Translation.
- 17 Apr 2026
- Cancer communications (London, England)
EPO receptor blockade in dendritic cell enhances antitumor CD8⁺ T cell immunity
- 14 Apr 2026
- Cancer Communications
The Roles of Protein S-Palmitoylation in Cancers: From Dynamic Modulation to Therapeutic Potential
- 2 Apr 2026
- Cancer Communications
Rezivertinib in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Central Nervous System Metastasis: Central Nervous System Efficacy from the Phase III REZOR Study
- 31 Mar 2026
- Cancer Communications
DKK1 Suppresses Hippo Signaling via PIP3-OGT-LRP6 O-GlcNAcylation in Hepatocellular Carcinoma
- 27 Mar 2026
- Cancer Communications
FAQs on Chinese Journal of Cancer
How many articles did Chinese Journal of Cancer publish last year? 
What is the eISSN & pISSN for Chinese Journal of Cancer?
Who is the publisher of Chinese Journal of Cancer?
